Plea To Lower Age For Mammography Screening In The UK (p 246)July 16, 2003Two leading UK cancer experts are calling for the entry age for mammographic screening for breast cancer to be reduced from 50 to 47 years for women in the UK. Their rationale is detailed in a correspondence letter in this week's issue of THE LANCET. Screening mammography became widely available from the UK National Health Service in the late 1980s. Women aged 50-64 years are invited for screening every three years. Considerable debate surrounds the ideal age for women to enter screening programmes; an ongoing trial due to report at the end of 2004 could recommend lowering the entry age to women in their 40s. Peter Sasieni and Jack Cuzick (both leading scientists at Cancer Research UK) believe there is sufficient evidence now to lower the entry age for screening ahead of the ongoing research. Peter Sasieni comments: "At age 40 years, the annual rate of breast cancer is 79 per 100 000 women, but rises substantially to 148 per 100 000 women at age 47 years and 152 per 100 000 women at age 48 years. Between age 48 and 54 years, the rates of breast cancer plateau before again increasing more slowly reaching 221 per 100 000 women by age 64 years. Thus, the incidence rate of breast cancer at age 48-49 years is as great as that at age 50-54 years, and the number of life-years that could be saved is potentially greater among these younger women." Jack Cuzick adds: "Although it is justifiable not to screen women in their early 40s without additional evidence, the case for offering screening to women aged 47 years is as strong as the case for offering screening to women aged 50 years. Starting mammographic screening at age 47 years, rather than at age 48 years, allows for a 1 year lead-time for screen-detected cancers. We propose that it is time to begin screening at age 47 years in all women, with screening every 3 years thereafter." | |||||||||||||||||||||
|
Related Breast Cancer Current Events and Breast Cancer News Articles Angled gantry technique reduced breast radiation exposure by 50 percent A novel angled gantry approach to coronary CT angiography reduced radiation exposure to the breast by more than 50%, according to Thomas Jefferson University researchers. HER2 levels may aid in treatment selection for metastatic breast cancer Findings published in the December 1, 2008, issue of Clinical Cancer Research, a journal of the American Association for Cancer Research, show lapatinib benefits women with HER2-positive breast cancer, while women with HER2-negative breast cancer or those who express EGRF alone derive no incremental benefit. Drop in cancer deaths tied primarily to gains in behavior and screening Improvements in behavior and screening have contributed greatly to the 13 percent decline in cancer mortality since 1990, with better cancer treatments playing a supporting role, according to new research from David Cutler of Harvard University. New breast imaging technology targets hard-to-detect cancers Breast-specific gamma imaging (BSGI) is effective in the detection of cancers not found on mammograms or by clinical exam, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA). Delays in Radiation Therapy Lead to Increased Breast Cancer Recurrence A new analysis of the National Cancer Institute's cancer registry has found that as many as one in five older women experience delayed or incomplete radiation treatment following breast-conserving surgery, and that this suboptimal care can lead to worse outcomes. New mammography technology effective in detecting breast cancer A study has found that positron emission mammography (PEM), a new technique for imaging the breast, is not affected by either breast density or a woman's hormonal status, two factors that limit the effectiveness of standard mammography and MRI at detecting cancer. New statistical model could help reduce breast-lesion biopsies A new method of characterizing breast lesions found during an MRI exam could result in fewer biopsies of benign tumors with the benefits of reduced pain and expense for patients and providers, according to a paper that will be presented today (Sunday, Nov. 30) at the annual meeting of the Radiological Society of North America (RSNA). Breast cancer treatment offers better outcome to women with implants Women with early-stage breast cancer who have undergone breast augmentation may be treated successfully with a partial-breast radiation treatment called brachytherapy, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA). Study identifies double-balloon enteroscopy as cost-effective approach for obscure GI bleeding A cost-effectiveness analysis conducted by researchers at Stanford University Hospital in Calif., shows that an initial double-balloon enteroscopy (DBE) is a cost-effective approach for patients with obscure gastrointestinal (GI) bleeding. Study identifies causes of bone loss in breast cancer survivors Osteoporosis is a growing concern among breast cancer survivors and their doctors, because certain cancer drugs can cause bone loss. More Breast Cancer Current Events and Breast Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||